selection and use of the new and coming therapies for ibd? who? when? how?
Published 8 years ago • 1.3K plays • Length 18:23Download video MP4
Download video MP3
Similar videos
-
20:54
selection and use of the non-anti-tnf biological therapies? who? when? how?
-
12:48
ibd clinical update: new and emerging targeted therapies
-
17:48
case-based discussion: individualizing ibd treatment goals and therapeutic selection
-
21:36
keynote: evolution of disease management in ibd
-
20:09
recent and emerging crohn's disease therapies
-
49:17
the evolving therapeutic paradigm in ibd: optimal positioning of new and emerging agents
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
21:25
first-line therapy options in ibd: understanding longitudinal severity
-
13:54
aminosalicylates in ibd: new data on an old therapy
-
22:19
vaccinations and ibd patients: what, when, and why?
-
21:36
crohn's disease: recent and emerging therapies
-
21:30
ibd: beyond combination therapy
-
27:12
evaluating and treating pain in ibd
-
15:15
first line therapies for ulcerative colitis and crohn's disease
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
26:10
recent and emerging ulcerative colitis therapies
-
41:15
targeting ibd: hitting the mark in today’s treatment landscape
-
6:22
antibiotics and risk of new onset inflammatory bowel disease: a meta-analysis
-
25:22
ibd and pregnancy